phase 0_trial_completion
saveDana-Farber Cancer Institute Inc — atezolizumab (Phase 0 Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Hepatocellular Carcinoma, Liver Cancer
Data sources
globaldata
Found something off?
drug timeline · 8
- phase 2 completionArcus Biosciences Inc — atezolizumab (Phase II Trial Completion)Apr 30, 2026 · 160d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalNov 17, 2025 · 324d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalOct 2, 2025 · 370d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalAug 18, 2025 · 415d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalApr 22, 2024 · 898d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 12, 2023 · 1244d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 12, 2023 · 1244d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalDec 9, 2022 · 1398d ago
related news · 8
- endpointsDesign Therapeutics' Friedreich's ataxia data; Vincentage's obesity results from China
- oncliveDr Hafron on the FDA Approval of Adjuvant Atezolizumab in MRD+ MIBC
- oncliveFDA Approves Adjuvant Atezolizumab for MRD+ Muscle-Invasive Bladder Cancer
- oncliveDana-Farber Study Finds Stage IV Breast Cancer Increasing in Incidence and Proportion Over the Last Decade
- oncliveGU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
- onclivePost–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer
- oncliveGiants of Cancer Care Announces the 14th Annual Class of Inductees
- oncliveTrack the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026
🐶 often sniffed alongside
top 8- drugTECENTRIQ178 co-mentions · 46 sources
- tagApproval176 co-mentions · 44 sources
- companyGenentech Inc88 co-mentions · 44 sources
- drugTECENTRIQ HYBREZA20 co-mentions · 5 sources
- drug(atezolizumab + hyaluronidase (human recombinant))10 co-mentions · 5 sources
- tagOncology5 co-mentions · 2 sources
- companyDana-Farber Cancer Institute Inc1 co-mentions · 1 sources
- tagHepatology1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that